Structure of Temozolomide CAS 85622-9Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions and Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

85622-93-1

Name

Temo­zolo­mide

Syn­onyms

3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazin-8-carboxamid [Ger­man] [ACD/IUPAC Name] 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide [ACD/IUPAC Name] 3-Méthyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tétrazine-8-carboxamide [French] [ACD/IUPAC Name] 85622-93-1 [RN] Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo- [ACD/​Index Name] MandB 39831 Temodal [Trade name] TEMODAR [Trade name] Temo­zo­lamide Temo­zolo­di­da [Span­ish] [INN] Temo­zolo­mide [BAN] [INN] [JAN] [USAN] [Wiki] Temo­zolo­midum [Latin] [INN] UNII :YF1K15M17Y [147127-20-6] 208107-14-6 [RN] 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide 3,4-dihydro-3-methyl-4-oxo-imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide 3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide 3-Methyl-4-oxo-3,4-dihydroimidazo-[5,1-d][1,2,3,5]tetrazine-8-carboxamide 3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide 3-methyl-4-oxo-3H,4H-imidazo[4,3-d][1,2,3,5]tetrazine-8-carboxamide 3-methyl-4-oxo-8-imidazo[5,1-d][1,2,3,5]tetrazinecarboxamide 3-Methyl-4-oxo-8-imidazolo[5,1-d][1,2,3,5]tetrazinecarboxamide 3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide 3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide 3-methyl-4-oxoimidazo[5,1-d]1,2,3,5-tetraazine-8-carboxamide 4-keto-3-methyl-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide 4-Methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide 8-carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one 8-Carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one BR-72945 C047246 CCRG-81045|M-39831|Temodal®|Temodar® CCRIS 8996 D06067 Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo- Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihy­­dro-3-methyl-4-oxo- M and B 39831 MandB-39831 M-39831 Met­ha­zo­la­s­tone Met­ha­zo­la­s­tone, Temodar, Temodal MFCD00866492 [MDL num­ber] MFCD07357269 MLS000759447 NJ5927050 NSC 362856 | CCRG 81045 | NSC 362856 ; CCRG 81045 ; TZM OR-2567 Phar­­makon1600-01502289 SMR000466338 Temodal (TN) Temodal® Temodal ; Temodar Temodar® Temo­zolim­ide Temo­zolo­di­da Temo­zolo­di­da ; Temo­zolo­mid ; Témo­zolo­mide ; Temo­zolo­midum Temo­zolo­mid temo­zolo­mi­da temo­zolo­mi­da ; temo­zolo­mide ; temo­zolo­midum Témo­zolo­mide Temo­zolo­midum Temo­zolo­midum [Latin] TL8005593 TMZ TMZ ; NSC 362856 ; SCH 52365 ; CCRG 81045 TZM UNII-YF1K15M17Y YF1K15M17Y

Mol­e­c­u­lar Structure

Structure of Temozolomide CAS 85622-9

Struc­ture of Temo­zolo­mide CAS 85622-9

SMILES

Cn1c(=O)n2cnc(c2nn1)C(=O)N

Std­InChI

InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)

Std­InChIKey

BPEGJWRSRHCH­SN-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C6H6N6O2

Mol­e­c­u­lar Weight

194.15

MDL Number

MFCD00866492

Prop­er­ties

Appear­ance

White to almost red­dish pow­der

Safe­ty Data

Sym­bol

exclamation-mark-jpgexclamation-mark-jpgGHS07, GHS08

Sig­nal Word

Dan­ger

Haz­ard Statements

H302-H315-H319-H335-H350-H360

Pre­cau­tion­ary Statements

P201-P261-P305 + P351 + P338-P308 + P313

Per­son­al Pro­tec­tive Equipment

Eye­shields, full-face par­ti­cle res­pi­ra­tor type N100 (US), Gloves, res­pi­ra­tor car­tridge type N100 (US), type P1 (EN143) res­pi­ra­tor fil­ter, type P3 (EN 143) res­pi­ra­tor car­tridges

RIDADR

NONH for all modes of trans­port

WGK Germany

3 

RTECS

NJ5927050

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Temo­zolo­mide CAS 85622-93-1

Stan­dard

CP2015

Iden­ti­fi­ca­tion Methods

HPLC,IR

Assay

98%~102%

Heavy Met­als

10ppm max

Loss on Drying

0.5%max

Resid­ual solvent

DMSO : ≤5000ppm

Residue on Ignition

0.1%max

Known Impu­ri­ty

0.5%max

Unknown Impu­ri­ties

0.5%max

Total Impu­ri­ties

1.0%max

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing.

Stor­age

Under the room tem­per­a­ture and away from light.

Appli­ca­tion

Com­mon­ly used as anti-can­cer drugs. In the body can spon­ta­neous­ly and rapid­ly degrade the active metabo­lite MTIC, result­ing in anti-tumor effect.

Links

This prod­uct is devel­oped by our RandD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​t​e​m​o​z​o​l​o​m​i​d​e​-​c​a​s​-​8​5​6​2​2​-​9​3​-1/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the car.




    andD pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.